glp-1 is what medications get at the heart of addiction: study – WashU Medicine GLP-1-based therapies for type 2

M., Mason, N

What are the new findings

If you were a betting person, youd probably bet that wed end up with nothing. Its very rare, frankly, that something goes this way and that frequently its a combination of luck, some intelligence, some foresight into doing the right experiments, Raufman said

Glucose may be further metabolised by pyruvate dehydrogenase and pyruvate carboxylase, resulting in enhanced tricarboxylic acid cycle activity and subsequent ATP generation [1]

Retrieved June 4, 2014

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial